Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus
2010 · Arthritis Research & Therapy · 78 citations
https://doi.org/10.1186/ar2887